Neurotrophins and Peripheral Neuropathies

Overview

Journal Brain Pathol

Date 2006 Nov 17

PMID 17107601

Citations 10

Authors

Zarife Sahenk

Affiliations

Soon will be listed here.

Abstract

Peripheral neuropathy is a common disorder seen in general neurology and neuromuscular specialty clinics. Treatment options directed at the underlying cause can only be offered in a handful of conditions, such as those with possible autoimmune etiology. The remainder fall into the idiopathic or genetic category with no known treatment. This review surveys the evidence supporting the rationale for the therapeutic use of neurotrophins and other neurotrophic factors in these disorders in relationship to the underlying pathobiological process. Previous clinical trials are assessed, and increasingly better understood and appreciated therapeutic potential of neurotrophins is emphasized.

Citing Articles

AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis.

Tong L, Ozes B, Moss K, Myers M, Attia Z, Vetter T Gene Ther. 2025; .

PMID: 39972161 DOI: 10.1038/s41434-025-00518-9.

AAV1.tMCK.NT-3 gene therapy improves phenotype in mouse model of Charcot-Marie-Tooth Type 4C.

Ozes B, Tong L, Moss K, Myers M, Morrison L, Attia Z Brain Commun. 2024; 6(6):fcae394.

PMID: 39544702 PMC: 11562120. DOI: 10.1093/braincomms/fcae394.

Elongator promotes neuritogenesis regulation of tau stability through acly activity.

Shilian M, Even A, Gast H, Nguyen L, Weil M Front Cell Dev Biol. 2022; 10:1015125.

PMID: 36393857 PMC: 9644021. DOI: 10.3389/fcell.2022.1015125.

New Therapeutics Options for Pediatric Neuromuscular Disorders.

Flotats-Bastardas M, Hahn A Front Pediatr. 2020; 8:583877.

PMID: 33330280 PMC: 7719776. DOI: 10.3389/fped.2020.583877.

Gene therapy to promote regeneration in Charcot-Marie-Tooth disease.

Sahenk Z, Ozes B Brain Res. 2019; 1727:146533.

PMID: 31669284 PMC: 6939124. DOI: 10.1016/j.brainres.2019.146533.

References

Sahenk Z, Serrano-Munuera C, Chen L, Kakabadze I, Najagara H . Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts. J Peripher Nerv Syst. 2003; 8(2):116-27. DOI: 10.1046/j.1529-8027.2003.03017.x. View

Tokuoka H, Saito T, Yorifuji H, Wei F, Kishimoto T, Hisanaga S . Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons. J Cell Sci. 2000; 113 ( Pt 6):1059-68. DOI: 10.1242/jcs.113.6.1059. View

Boyd J, Gordon T . Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp Neurol. 2003; 183(2):610-9. DOI: 10.1016/s0014-4886(03)00183-3. View

Blesch A . Neurotrophic factors in neurodegeneration. Brain Pathol. 2006; 16(4):295-303. PMC: 8095767. DOI: 10.1111/j.1750-3639.2006.00036.x. View

Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, Solders G . A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004; 13(8):799-805. DOI: 10.1093/hmg/ddh096. View

Schratzberger P, Walter D, Rittig K, Bahlmann F, Pola R, Curry C . Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest. 2001; 107(9):1083-92. PMC: 209283. DOI: 10.1172/JCI12188. View

Clark E, Lee V . The differential role of protein kinase C isozymes in the rapid induction of neurofilament phosphorylation by nerve growth factor and phorbol esters in PC12 cells. J Neurochem. 1991; 57(3):802-10. DOI: 10.1111/j.1471-4159.1991.tb08222.x. View

Simovic D, Isner J, Ropper A, Pieczek A, Weinberg D . Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol. 2001; 58(5):761-8. DOI: 10.1001/archneur.58.5.761. View

Milbrandt J, Johnson Jr E . NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron. 2002; 33(2):261-73. DOI: 10.1016/s0896-6273(01)00585-2. View

10.

Lindenbaum M, Carbonetto S, Mushynski W . Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells. J Biol Chem. 1987; 262(2):605-10. View

11.

Apfel S, Kessler J, Adornato B, Litchy W, Sanders C, Rask C . Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology. 1998; 51(3):695-702. DOI: 10.1212/wnl.51.3.695. View

12.

Storkebaum E, Lambrechts D, Carmeliet P . VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays. 2004; 26(9):943-54. DOI: 10.1002/bies.20092. View

13.

Li H, Wigley C, Hall S . Chronically denervated rat Schwann cells respond to GGF in vitro. Glia. 1998; 24(3):290-303. View

14.

Li H, Terenghi G, Hall S . Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo. Glia. 1997; 20(4):333-47. DOI: 10.1002/(sici)1098-1136(199708)20:4<333::aid-glia6>3.0.co;2-6. View

15.

Sahenk Z, Nagaraja H, McCracken B, King W, Freimer M, Cedarbaum J . NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology. 2005; 65(5):681-9. DOI: 10.1212/01.wnl.0000171978.70849.c5. View

16.

Hammarberg H, Piehl F, Cullheim S, Fjell J, Hokfelt T, Fried K . GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury. Neuroreport. 1996; 7(4):857-60. DOI: 10.1097/00001756-199603220-00004. View

17.

Ter Laak M, Hamers F, Kirk C, Gispen W . rhGGF2 protects against cisplatin-induced neuropathy in the rat. J Neurosci Res. 2000; 60(2):237-44. DOI: 10.1002/(SICI)1097-4547(20000415)60:2<237::AID-JNR13>3.0.CO;2-5. View

18.

Goebel H, Veit S, Dyck P . Confirmation of virtual unmyelinated fiber absence in hereditary sensory neuropathy type IV. J Neuropathol Exp Neurol. 1980; 39(6):670-5. DOI: 10.1097/00005072-198011000-00005. View

19.

Lemke G, Brockes J . Identification and purification of glial growth factor. J Neurosci. 1984; 4(1):75-83. PMC: 6564755. View

20.

Jessen K, Mirsky R . Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 1999; 22(9):402-10. DOI: 10.1016/s0166-2236(98)01391-5. View